MACROGENICS INC (MGNX:NASDAQ)
$3.72 -0.02 (-0.5348%)
Analysed MACROGENICS INC (MGNX:NASDAQ) News Sources
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
13-08-2026
yahoo.com
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
23-09-2026
yahoo.com
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
22-06-2026
yahoo.com
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
02-07-2026
yahoo.com
Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
02-07-2026
yahoo.com
MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy?
02-07-2026
yahoo.com
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
11-08-2026
yahoo.com
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
15-08-2026
yahoo.com
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
09-09-2026
yahoo.com
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
09-10-2026
yahoo.com
What is the current price of MACROGENICS INC (MGNX:NASDAQ)?
The current price of MACROGENICS INC (MGNX:NASDAQ) is $3.72.
MACROGENICS INC (MGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MACROGENICS INC (MGNX:NASDAQ) since the previous trading day is $-0.02.
MACROGENICS INC (MGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MACROGENICS INC (MGNX:NASDAQ) since the previous trading day is -0.5348%.
What is the most recent average sentiment score for MACROGENICS INC (MGNX:NASDAQ)?
The most recent average sentiment score for MACROGENICS INC (MGNX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for MACROGENICS INC (MGNX:NASDAQ)?
The most recent sentiment for MACROGENICS INC (MGNX:NASDAQ) is .
SEC-8K** Filing Available For MACROGENICS INC (MGNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.